This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 114/22/2364    most recent CIRCULATIONAHA.106.642454v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yajima, T. Articles by Knowlton, K. U. Search for Related Content PubMed PubMed Citation Articles by Yajima, T. Articles by Knowlton, K. U. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Genetics Home Reference Medline Plus Health Information Viral Infections Related Collections Other heart failure Animal models of human disease Myocardial cardiomyopathy disease

(Circulation. 2006;114:2364-2373.)
© 2006 American Heart Association, Inc.

Molecular Cardiology

Innate Defense Mechanism Against Virus Infection Within the Cardiac Myocyte Requiring gp130-STAT3 Signaling

Toshitaka Yajima, MD, PhD^*; Hideo Yasukawa, MD, PhD^*; Eun-Seok Jeon, MD, PhD; Dingding Xiong, MD, PhD; Andrea Dorner, PhD; Mitsuo Iwatate, MD, PhD; Miwako Nara, PhD; Hanbing Zhou, BS; Daphne Summers-Torres, BS; Masahiko Hoshijima, MD, PhD; Kenneth R. Chien, MD, PhD; Akihiko Yoshimura, PhD; Kirk U. Knowlton, MD

From the Department of Medicine (T.Y., E-S.J., D.X., A.D., M.N., H.Z., D.S-T., K.U.K.) and Institute of Molecular Medicine (H.Y., M.I., M.H., K.R.C.), University of California, San Diego, La Jolla; Cardiovascular Research Institute and the Third Department of Medicine, Kurume University School of Medicine (H.Y.), Kurume, Japan; Department of Medicine, Sungkyunkwan University School of Medicine (E.-S.J.), Seoul, South Korea; Charite-Campus Benjamin Franklin, Cardiology and Pneumology (A.D.), Berlin, Germany; Medical Institute of Bioregulation, Division of Molecular and Cellular Immunology (A.Y.), Kyushu University, Fukuoka, Japan.

Correspondence to Kirk U. Knowlton, MD, Department of Medicine, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093–0613K. E-mail kknowlton{at}ucsd.edu

Received May 27, 2006; revision received August 23, 2006; accepted September 15, 2006.

Background— Little is known about innate immune mechanisms within the cardiac myocyte that determine susceptibility to enterovirus infection, an important cause of myocarditis and subsequent heart failure. Although interferon (IFN) generally plays a key role in innate immunity, ablation of IFN receptors has little or no effect on acute coxsackievirus B3 infection in the heart. Interestingly, gp130-cytokine–mediated stimulation of neonatal ventricular myocytes has a cytoprotective effect against virus infection in culture that can be inhibited by suppressors of cytokine signaling (SOCS)-3, a physiological inhibitor of gp130 signaling that does not affect IFN signaling. Therefore, we hypothesized that inhibition of gp130 signaling by SOCS3 would change cardiac myocyte susceptibility to virus infection without affecting IFN signaling.

Methods and Results— We generated cardiac-specific SOCS3 transgenic mice. Despite an intact IFN-mediated antiviral response in adult transgenic myocytes, there was a marked increase in susceptibility to viral infection in the SOCS3 transgenic mouse hearts. This indicated the presence of IFN-independent innate defense mechanisms within the cardiac myocyte. Subsequently, we demonstrated that cardiac-specific gp130-knockout mice also had increased susceptibility to viral infection. Furthermore, we demonstrated that the gp130-mediated increase in survival of infected myocytes occurred through a signal transducers and activators of transcription-3–dependent mechanism that did not affect viral replication. This was accompanied by a persistent expression of full-length dystrophin after coxsackievirus B3 infection. In addition, we found that both SOCS3 transgenic and gp130-deficient mice had a decrease in -sarcoglycan.

Conclusions— SOCS3-mediated regulation of gp130 signaling can affect susceptibility to viral infection in the heart. Increased cardiac cell survival through gp130–signal transducers and activators of transcription-3 signaling appears to play an important role in preserving nondividing cardiac myocytes until specific immune responses begin to clear the virus.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				M. Kurdi and G. W. Booz JAK redux: a second look at the regulation and role of JAKs in the heart Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1545 - H1556. [Abstract] [Full Text] [PDF]

				T. Yajima and K. U. Knowlton Viral Myocarditis: From the Perspective of the Virus Circulation, May 19, 2009; 119(19): 2615 - 2624. [Full Text] [PDF]

				S. Heymans, E. Hirsch, S. D. Anker, P. Aukrust, J.-L. Balligand, J. W. Cohen-Tervaert, H. Drexler, G. Filippatos, S. B. Felix, L. Gullestad, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail, February 1, 2009; 11(2): 119 - 129. [Abstract] [Full Text] [PDF]

				J. Zurney, K. E. Howard, and B. Sherry Basal Expression Levels of IFNAR and Jak-STAT Components Are Determinants of Cell-Type-Specific Differences in Cardiac Antiviral Responses J. Virol., December 15, 2007; 81(24): 13668 - 13680. [Abstract] [Full Text] [PDF]

				Y.-X. Wang, V. da Cunha, J. Vincelette, K. White, S. Velichko, Y. Xu, C. Gross, R. M. Fitch, M. Halks-Miller, B. R. Larsen, et al. Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H69 - H76. [Abstract] [Full Text] [PDF]

				Y. Maekawa, M. Ouzounian, M. A. Opavsky, and P. P. Liu Connecting the Missing Link Between Dilated Cardiomyopathy and Viral Myocarditis: Virus, Cytoskeleton, and Innate Immunity Circulation, January 2, 2007; 115(1): 5 - 8. [Full Text] [PDF]